German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...

AbbVie has agreed a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will give it control of a preclinical-stage, oral drug for psoriasis. US-based Nimble was set up in ...

Psoriatic arthritis (PsA) is a chronic inflammatory condition that may cause pain and disability. It may be managed with medication and lifestyle changes. While PsA isn’t life threatening ...

After two years, 1 in 4 people with psoriasis change from one biologic to another. Doing so can help improve your quality of life. Here’s what to know if you have to make a switch. [1] ...